
Abstract The recent expansion of recombinant biomolecules as diagnostic and therapeutic agents has created a strong need for mild, site-specific, and universally applicable methods to radiolabel them for positron emission tomography (PET). Fluorine-18 is one of the most widely used radionuclides for PET because it combines a clinically practical half-life, high positron intensity with low mean energy, and a non-metallic footprint in the label. However, the conditions necessary for efficient nucleophilic fluorine-18 radiolabelingbasic, anhydrous media, elevated temperature, and aprotic solventsare poorly compatible with sensitive biomolecules. Therefore, prosthetic group labeling with subsequent conjugation, both site-specific and non-site-specific, and aluminum-[18F]fluoride (Al[18F]F2+) chelation have become essential workarounds. Depending on the radiolabeling site, this can yield heterogeneous products, with impaired tracer target binding and pharmacokinetics. Enzymatic ligation offers a complementary strategy, with radiofluorination done on a robust small-molecule or peptide substrate, and subsequently, an enzyme catalyzes a mild and site-specific conjugation to a genetically encoded recognition motif on the target. This ensures that each step proceeds under its own optimal conditions. This review evaluates the current state of enzymatic and chemoenzymatic radiofluorination of biomolecules, from the early fluorinase work to recent advances with lipoic acid ligase (LplA), peptide asparaginyl ligase, and sortase A (SrtA). It further reviews enzymes and techniques that could extend this toolbox. The field is still emerging, but available evidence suggests that enzyme-mediated radiofluorination can occupy a niche between classical prosthetic-group radiochemistry and kit-like radiometal labeling, especially for fragile recombinant biomolecules whose radiolabeling with fluorine-18 is currently a challenge.
Abstract Disulfide bonds are structural elements, redox-responsive motifs, and native entry points for protein modification, yet most disulfide-directed workflows generate readouts only after reduction to free thiols. Reduction−alkylation, one-pot reductive conjugation, and rebridging are powerful because they convert S−S bonds into tractable nucleophiles or synthetic bridges; however, their final products usually report reduced-state sulfur reactivity or restored connectivity rather than the chemical state created during initial disulfide activation. We propose an activation-state framework that separates three properties: cysteine-pair connectivity, preservation of the native S−S bond, and activation-state lineage. We focus on thiophosphonium-gated capture, in which phosphine attack generates a transient thiophosphonium/thiolate pair and an attenuated electrophile carries the sulfur represented in the thiophosphonium manifold into a stable conjugate. The product thereby retains the lineage of the sulfur that entered the activated manifold rather than that of the sulfur released during cleavage. We define the operational evidence required for this assignment and discuss three-component gating, competing pathway fluxes, reagent architecture, and translation from model disulfides to proteins.
Abstract The concentration of biologically relevant metal cations can be monitored with subcellular precision thanks to chemogenetic fluorescent indicators that combine a small molecular probe with a recombinant protein tag, but despite a few reported examples emitting in the blue/green range, such indicators remain underexplored in the case of Zn2+ cations. Using a combination of rational and theoretical design, we report a series of hybrid fluorescent zinc indicators based on a hemicyanine scaffold with a red fluorescence emission. The photoinduced electron transfer (PeT) underlying the sensing mechanism was studied by density functional theory (DFT) calculations to guide the probe design, leading to the development of two zinc indicators, HemiZin-2 and HemiZin-3, that were successfully used to detect exogenously applied zinc in live cells by confocal microscopy with subcellular resolution. This study evidences the complementarity between the rational design and the theoretical calculations to fast-track the probe design. It also emphasizes the importance of the interaction with HaloTag that strongly improves the brightness of the viscosity-sensitive hemicyanine and can also be used to fine-tune the affinity of the resulting complex, opening new possibilities for the design of genetically encoded PeT-based sensors for Zn2+ or other metal cations.
Abstract Bioorthogonal bond-cleavage chemistry with rapid kinetics in both the click and release steps is essential for optimal performance in complex biological systems. Herein, through screening a focused library of α-nucleophiles, we discovered a new bioorthogonal click-and-release strategy employing N-monoalkyl-substituted hydroxylamines and cyclooctynes. Systematic structural modification of the N-substituent was then carried out to tune the click kinetics. This optimization campaign led to the identification of several analogues that exhibit fast click reaction kinetics (k2 = ∼103 M−1 s−1). However, a consistent trade-off between click kinetics and bond-cleavage efficiency was observed due to regioselectivity issues in the click step, which somewhat limits the broad applicability of this strategy. Future efforts are therefore warranted to address this trade-off and fully unleash its potential for biological applications.
Antibody drug conjugates (ADCs) are a promising class of therapeutics in cancer treatment. However, the general design principles of ADCs are yet to be established. We hypothesized that shielding the linker payload within the Fc cavity could mitigate premature exposure of linker payloads during systemic circulation and improve in vivo efficacy. To achieve this goal, we employed engineered cysteines and screened conjugation sites to find an optimal site which can mask a payload in the Fc cavity. Through a cathepsin cleavage assay and hydrophobic interaction chromatography, several conjugation sites were identified to produce drug-to-antibody ratio (DAR) 2 Fc cavity ADCs. Among the identified sites, V264C exhibited the strongest payload-shielding effect. Using a molecular-ruler approach, we further quantified the payload-accommodating capacity of each Fc cavity conjugation site and found substantial site-dependent differences in cavity size. The single mutations were further combined to generate DAR4 ADCs, leading to the identification of a practical site selection guideline for engineered cysteine-based DAR4 Fc cavity ADCs. An intermutation distance of ∼ 20 Å emerged as a practical threshold for selecting compatible mutation pairs in DAR4 Fc cavity ADCs. Both the DAR2 and DAR4 Fc cavity ADCs showed improved in vivo efficacy compared with the randomly conjugated ADCs.